DRTECH Corporation
Financials
Valuation Metrics
DRTECH Corporation's Market Cap is ₩557B. At end of 2025 it was ₩1757B. Ranked #1635 of 2,405 in KR market (top 68%), #972 of 1,627 on KOSDAQ (top 60%), #63 of 94 in Health Care Equipment & Services (top 67%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 55.67B KRW | KR#1,635/2,405 Sec#63/94 |
| Revenue | 126.23B KRW | KR#1,279/2,405 Sec#21/94 |
| Net Income | -12.53B KRW | KR—/2,405 Sec—/94 |
| Total Assets | 235.84B KRW | KR#1,190/2,405 Sec#30/94 |
| Net Assets | 84.82B KRW | KR#1,539/2,405 Sec#44/94 |
| Employees | 367 | KR#656/2,405 Sec#15/94 |
| Value | ||
| P/B | 0.66x | KR#1,129/2,405 Sec#22/94 |
| P/S | 0.44x | KR#885/2,405 Sec#7/94 |
| FCF Yield | -47.80% | KR—/2,405 Sec—/94 |
| Profitability | ||
| ROE | -14.78% | KR#2,012/2,405 Sec#72/94 |
| ROA | -5.31% | KR#1,942/2,405 Sec#65/94 |
| Op. Margin | -7.94% | KR#1,933/2,405 Sec#60/94 |
| Revenue Growth | 11.84% | KR#807/2,405 Sec#40/94 |
| Financial Health | ||
| Debt Ratio | 178.06% | KR#2,015/2,405 Sec#86/94 |
| Total Debt | 105.97B KRW | KR#705/2,405 Sec#13/94 |
| FCF | -26.61B KRW | KR#1,950/2,405 Sec#74/94 |
| Cash | 36.28B KRW | KR#896/2,405 Sec#23/94 |
| Current Ratio | 1.94x | KR#890/2,405 Sec#51/94 |
| Dividend | ||
| Div. Growth | 0.00% | KR—/2,405 Sec—/94 |
| Performance | ||
| 1Y Return | -66.36% | KR#2,225/2,405 Sec#86/94 |
| 1M Return | -14.81% | KR#1,569/2,405 Sec#63/94 |
| From 52W High | -71.80% | KR#2,110/2,405 Sec#81/94 |
| 1Y MDD | -72.27% | KR#2,053/2,405 Sec#77/94 |
| Trading | ||
| Volume | 19,510 shares | KR#1,497/2,405 Sec#57/94 |
| Trading Value | 64.4M KRW | KR#1,604/2,405 Sec#63/94 |
| Foreign Own. | 0.00% | KR—/2,405 Sec—/94 |
| Per Share | ||
| EPS | -751 KRW | KR—/2,405 Sec—/94 |
| BPS | 5,081 KRW | KR#1,489/2,405 Sec#36/94 |
Company Info
DRTECH, established in 2000 and listed on KOSDAQ in 2016, is a digital diagnostic imaging solution company. Leveraging over 20 years of imaging diagnosis technology, it uniquely offers total solutions encompassing all X-ray systems and components, integrating system, software, and detector into a unified platform. The company maintains global operations with approximately 80% of its sales from overseas and is expanding its market influence with digital mammography upgrade solutions and a full product lineup. DRTECH is headquartered in Seongnam-si, Gyeonggi-do.